Keywords: Emergen BioSolutions, VaxInnate Corp, US rights, Pandemic flu vaccine candidate

Emergent BioSolutions gets exclusive US commercial rights to pandemic flu vaccine candidate

Article | 31 December 2012

US vaccine maker Emergent BioSolutions (NYSE: EBS) has signed a license agreement with fellow USA-based privately-held biotech firm VaxInnate Corp ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Emergent BioSolutions

VaxInnate Corp

Go to company listing